Background: Few studies have compared diets to determine whether a program focused on 1 dietary change results in collateral effects on other untargeted healthy diet components.
H
ealthy diet and lifestyle behaviors are the cornerstone of cardiometabolic health, and strong evidence supports the efficacy of the American Heart Association (AHA) diet in preventing and treating the metabolic syndrome (1, 2) . However, the various AHA dietary recommendations may create adherence challenges (3, 4) . The AHA dietary goals include consuming vegetables and fruits; eating whole grains and highfiber foods (≥30 g/d); eating fish twice weekly; consuming lean animal and vegetable proteins; reducing intake of sugary beverages; minimizing sugar and sodium intake; maintaining moderate to no alcohol intake; consuming 50% to 55% of calories from carbohydrates, 15% to 20% of calories from protein, and 30% to 35% of calories from fat; and limiting saturated fat to less than 7% of energy, trans fat to less than 1% of energy, and cholesterol to less than 300 mg/d.
Few studies have explored weight loss outcomes as they relate to different dietary messages, such as "eat more of this" (permissive) or "do not eat that" (restrictive), and which, if any, of these messages result in collateral effects on other unadvised healthy diet components. Spring and colleagues (5) found that a group encouraged to eat more fruits and vegetables, while reducing sedentary time, made greater improvements in all behaviors (including untargeted and unadvised aspects) than the group encouraged to reduce saturated fat and increase physical activity. The permissive dietary advice in Spring and colleagues' study (that is, increase fruit and vegetable intake) had more collateral effects than the restrictive advice (that is, reduce saturated fat intake).
Our study compared the efficacy of 2 approaches for dietary change in participants with the metabolic syndrome: a fiber-focused diet and the AHA diet (6) . We hypothesized that the fiber-focused group would be superior to the AHA intervention for weight loss, dietary quality, metabolic health, and adherence at 12 months. 119). Research staff assessing outcomes were blinded to the intervention assignment. The study protocols were approved by the University of Massachusetts Medical School Institutional Review Board, and the study's data safety and monitoring board reviewed each adverse event, which was reported to the Institutional Review Board. All participants gave informed consent.
Setting and Participants
Participants were recruited in 10 waves between June 2009 and January 2012 from Worcester, Massachusetts (ClinicalTrials.gov: NCT00911885; completed on 1 June 2009). Eligible participants were adults who met criteria for the metabolic syndrome (7), had a body mass index (BMI) of 30 to 40 kg/m 2 , were aged 21 to 70 years, had a physician's approval to participate, and were nonsmokers for 30 days or more. Exclusion criteria were clinically diagnosed diabetes or a fasting blood sugar level of 7 mmol/L (126 mg/dL) or more, an acute coronary event within the previous 6 months, pregnancy or lactation, the polycystic ovary syndrome, plans to move out of the area during the study, a medical condition that precludes dietary recommendations, major depression or suicidality, participation in any weight loss program, previous bariatric surgery or use of weight loss medication, and an eating disorder. Figure 1 shows how many participants were recruited, randomly assigned, and included in the analyses. Of the 1777 persons screened, 240 fulfilled the study criteria, gave consent, and were enrolled in the trial. Participants were stratified by sex and BMI categories (25 to 29.9 kg/m 2 vs. ≥30 kg/m 2 ). Within each stratum, participants were randomly assigned to the 2 interventions in randomly permuted block sizes of 6 through the RALLOC procedure using Stata, version 11.0 (StataCorp) (8) , to ensure that the distributions of sex and BMI were similar between the 2 interventions.
Randomization and Interventions
The primary outcome was weight loss at 12 months. A treatment goal for all participants was weight loss of 7% of baseline body weight; the AHA recommendation was weight loss of 6% to 10% for participants with the metabolic syndrome (9) . The AHA diet group was given individualized caloric goals to achieve weight loss. The high-fiber diet group's goal was to consume 30 grams or more of fiber per day. No caloric goals were given to these participants.
Intervention Format and Treatment Fidelity
The intervention consisted of 2 individual sessions and 12 group sessions described elsewhere (10) . The number and length of the sessions were determined on the basis of our experience in conducting dietary interventions in similar populations (11, 12) . Treatment fidelity was monitored by provider and auditor checklists. All sessions were audio-recorded, with 10% of the sessions randomly selected for review by an auditor.
High-Fiber Diet
Participants randomly assigned to the high-fiber diet group received instructions on how to increase their fiber intake, and no physical activity recommendations were made (13, 14) . To avoid any potential bias, we structured each session to discuss a specific fiber theme with accompanying packets. Audited recordings showed that deviation was minimal; more than 98% of the time, questions not relevant to fiber intake were redirected by the dietitian to include healthy options with fiber.
AHA Diet
Participants randomly assigned to the AHA diet group received instructions for the AHA diet, including increasing fiber. Energy intake goals were calculated and provided to the participant by estimating the daily calories needed to maintain the participant's baseline weight and subtracting 500 to 1000 calories per day to achieve a weekly weight loss of 0.5 to 0.9 kg. Each participant was given a customized goal of saturated fat grams allowed per day (7% of estimated calories), and no physical activity recommendations were made.
Outcome Measures
At the baseline and 3-, 6-, and 12-month visits, body weight and height were measured using a calibrated balance scale. Participants wore light clothes and removed shoes for height and weight measurements. Three unannounced 24-hour recalls were done on randomly selected days within a 3-week period (2 weekdays and 1 weekend) around the baseline and 6-and 12-month visits, plus 1 recall at the 3-month visit. Recalls were conducted by dietitians blinded to participants' intervention group and trained to use the Nutrition Data System for Research software, versions 2008 to 2012 (University of Minnesota Nutrition Coordinating Center). The dietary recalls were done by telephone, and participants were provided with 2-dimensional food portion models before the call. Dietary quality was measured by the Alternative Healthy Eating Index (15, 16) . Physical activity was assessed in the same call as the 24-hour dietary assessment. We have used this validated method in several previous studies (17) (18) (19) (20) (21) .
At each visit, use of medications and dietary supplements was documented by self-report and original container label information. Laboratory data consisted of fasting glucose level, fasting plasma insulin level, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) score, hemoglobin A 1c (HbA 1c ) level, lipid levels, high-sensitivity C-reactive protein (hsCRP) level, interleukin-6 level, tumor necrosis factor-␣ (TNF-␣) receptor 2 level, and blood pressure. The concentration of hsCRP was measured using an immunoturbidimetric assay on the Roche P-Modular system (Roche Diagnostics). Interleukin-6 and TNF-␣ receptor 2 levels were measured by an enzyme-linked immunosorbent assay (R&D Systems).
Statistical Analysis
The required number of participants for each group was estimated on the basis of the primary outcome measure, which was change in body weight. Sample size was calculated using the method developed by Frison and Pocock (22) . We assumed an SD of 14.3 kg for body weight and an autocorrelation coefficient between pretreatment and posttreatment weight of 0.95. With 95 complete participants per group, the hypothesized between-group difference in the change in body weight (1.6 kg) could be detected with more than 80% power at a 5% significance level. Considering a possible attrition rate of 20%, the number of participants in each group must be at least 120. Thus, a total of 240 participants were enrolled in the study.
All analyses were conducted by using SAS, version 9.2 (SAS Institute). Comparisons between groups for baseline characteristics were done by using t tests for continuous variables or chi-square tests for categorical variables. Linear mixed models (PROC MIXED) were For data that were right-skewed, which included HOMA-IR score, fasting plasma glucose level, fasting plasma insulin level, triglyceride levels, hsCRP level, interleukin-6 level, and TNF-␣ receptor 2 level, we used log-␥ models (PROC GLIMMIX) (23) . To determine whether there were between-group differences in adherence to the dietary goals, we compared groups by using the proportion of participants who met the 13 AHA goals with logistic regression models for repeated measures fitted by generalized estimating equations and included terms for time, group, and time-by-group interaction. Primary results presented under the mixed-model analysis assume that missing data follow a missing-atrandom framework. We conducted sensitivity analyses to explore how primary results might change under various informative missing scenarios. We used the multiple imputation-based SAS macro MIWithd developed by Roger (24, 25) . Under 2 of the missing-not-atrandom scenarios, missing weights for participants who stopped their diets and left the trial were multiply imputed using a reference group defined as the group of 18 participants who stopped their diets but remained in the trial. All multiple imputation analyses were done by using 1000 imputations and 1000 iterations in the Markov chain Monte Carlo burn-in and 500 iterations between imputations.
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RESULTS
The 1-year study completion rate was 89%; 12 participants (9.9%) dropped out of the high-fiber diet group and 15 participants (12.6%) dropped out of the AHA diet group ( P = 0.55). The average age of participants was 52 years, mean BMI was 35 kg/m 2 , 72% were women, and 86% had at least a college education (see Table 1 ). Average caloric intake was 1880 kcal/d, and total dietary fiber intake was 19.1 g/d. No meaningful between-group differences were found for baseline characteristics.
Body Weight and Waist Circumference
At 3 months, mean change in weight in the highfiber diet group was Ϫ1.6 kg (95% CI, Ϫ2.4 to Ϫ0.8 kg) compared with Ϫ2.0 kg (CI, Ϫ2.8 to Ϫ1.2 kg) in the AHA diet group; the mean between-group difference was 0.4 kg (CI, Ϫ0.6 to 1.5 kg). Weight loss was maintained in both groups at 6 and 12 months. At 12 months, weight loss was Ϫ2.1 kg (CI, Ϫ2.9 to Ϫ1.3 kg) and Ϫ2.7 kg (CI, Ϫ3.5 to Ϫ2.0 kg) for the high-fiber and AHA diet groups, respectively; the mean betweengroup difference was 0.6 kg (CI, Ϫ0.5 to 1.7 kg). The sensitivity analysis conducted to explore the robustness of these results to inform missingness provided similar estimates of the between-group differences in weight loss at 12 months but with wider confidence limits (Appendix Table 1 , available at www.annals.org). Reduction in waist circumference at 12 months was greater in the AHA diet group than the high-fiber diet group (mean group difference, 0.5 inches [CI, 0.1 to 1.0 inches]). For more details, see Table 2 and Figure 2 .
Dietary Intake
Participants in both treatment groups decreased their total caloric intake over the 1-year study duration: Ϫ200.0 kcal/d (CI, Ϫ313.2 to Ϫ86.9 kcal/d) versus Ϫ464.6 kcal/d (CI, Ϫ578.0 to Ϫ351.2 kcal/d) for the high-fiber and AHA diet groups, respectively (mean . Percentage of calories from protein was also significant at the 3-and 6-month visits. For more information about between-group differences at 3, 6, and 12 months, see Table 2 .
Blood Pressure and Metabolic Measures
Both diastolic and systolic blood pressures decreased during the trial, with no between-group differences. Fasting plasma insulin level; HOMA-IR score; HbA 1c level; total, low-density lipoprotein, and highdensity lipoprotein cholesterol levels; triglyceride levels, hsCRP level; interleukin-6 level; and TNF-␣ receptor 2 level also had no between-group differences ( Table 2) .
Medication Use and Physical Activity
At baseline, 44.5% of participants received antihypertensive medication in the AHA diet group compared with 47.9% in the high-fiber diet group, whereas 39.5% received lipid-lowering medication in the AHA diet group compared with 39.7% in the high-fiber diet group. No changes in the use of these 2 medication types during the trial were seen. Two participants in the high-fiber diet group added medications: 1 added glipizide, 2.5 mg/d, 10 days before their final measurements; the other added metformin, 850 mg/d, 3 months before final measurements. Data from these 2 participants did not affect final group results. No withinor between-group differences were found for total and leisure-time physical activity over time (data not shown).
Session Attendance and Adherence
For both groups, mean attendance was 7.9 of 14 sessions (SD, 3.9). The proportion of participants meeting the AHA dietary goals increased (Appendix Table  2 , available at www.annals.org), and no meaningful between-group differences were observed.
Adverse Events
A total of 16 "nondiabetes" adverse events were reported. It was determined that the causes of these adverse events were not treatment-related. Adverse events by group were summarized in Appendix Table 3 (available at www.annals.org). In total, 8 participants met the criteria for diabetes (HbA 1c level ≥6.5%) during the trial: 7 in the high-fiber diet group and 1 in the AHA diet group (P = 0.066) (Appendix Table 4 , available at www.annals.org).
DISCUSSION
No clear between-group differences were found, suggesting that a dietary intervention focusing on a targeted fiber goal may be able to achieve clinically meaningful weight loss similar to the widely applied, but more intense, AHA dietary guidelines. The present study also offers insight similar to Spring and colleagues' findings (5) However, the ways in which the dynamic of a diet are changed by the addition or removal of a nutrient to the diet are not completely understood and deserve further study. For example, increases in sugar intake were seen at the population level during the time when low-fat diets were highly recommended (26) . A dietary message that focuses on 1 dietary component, such as dietary fiber, is permissive-it encourages an increase in a healthy behavior-versus the AHA diet's restrictive message, which advises persons to limit an unhealthy behavior. Our findings are consistent with several metaanalyses that found little to no difference in diet studies comparing low-fat, low-carbohydrate, or Mediterranean diets on weight loss (27) .
Both intervention groups showed improvement in insulin resistance and fasting plasma insulin level during the trial. We were encouraged to see the decline of the fasting plasma insulin level and the HOMA-IR score in the high-fiber diet group at 12 months, possibly due to the longer-term effect of dietary fiber. Long-term improvements in insulin resistance and fasting plasma insulin level have significant clinical implications for patients with the metabolic syndrome (7) . National survey data indicate that the current average daily intake of dietary fiber is only 16 grams (28 -32), and a 2013 AHA report with national age-stratified data showed that only 7.1% of adults aged 40 to 59 years consumed 30 grams or more of fiber per day (33). As our study showed, increasing dietary fiber (34) may accompany other healthy dietary changes, with the potential to significantly improve metabolic health and positively affect public health.
Generalizability is limited because the sample consisted mostly of white women who were well-educated. Baseline fiber intake and dietary quality were already greater than the national average in our sample. We are unaware of data to support whether the same reComparison of High-Fiber and AHA Diets ORIGINAL RESEARCH sults could be hypothesized for other groups with a higher burden of adverse cardiometabolic health.
Drawbacks to the fiber-focused message may include missed information about other important dietary metrics. However, our study showed that untargeted aspects of diet improved in the high-fiber diet group (for example, the ratio of white vs. red meat consumed), possibly due to substituting high-fiber foods for less healthy foods. The exact amount of information to deliver in a dietary intervention remains an elusive question. The challenge is to identify the ideal amount of information to change behavior without overwhelming the participant (35) . Finally, we note that a diagnosis of diabetes using an HbA 1c level of 6.5% or more was not defined during the trial until 2012 (36) . We, therefore, had 6 patients with diabetes at baseline.
Although the primary goal of our study (for the high-fiber diet group to achieve superior weight loss) was not met, we found that a single component dietary intervention can achieve clinically meaningful weight loss similar to that of the multicomponent AHA diet. We were encouraged by the improvements in blood pressure, dietary quality, and insulin resistance, all of which are integral in the prevention of diabetes and cardiovascular disease and management of the metabolic syndrome. Disclaimer: The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the National Heart, Lung, and Blood Institute.
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Comparison of High-Fiber and AHA Diets (n ‫؍‬ 121)
Total vegetable and fruit intake ≥5 cups 15 (13) 16 (13) 30 (25) 22 (19) 15 (13) 24 (20) 21 (18) 20 (17) Whole-grain, high-fiber food intake (≥30 g/d of total fiber) 7 (6) 8 (7) 24 (20) 34 (28) 17 (14) 29 (24) 12 (10) 
